LFG
XERS icon

Larson Financial Group’s Xeris Biopharma Holdings XERS Stock Holding History

Larson Financial Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$603 Buy
+104
New +$690 ﹤0.01% 3280
2025
Q4 		– Sell
-400
Closed -$3.26K – 3689
2025
Q3 		$3.26K Buy
+400
New +$2.66K ﹤0.01% 2515

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Larson Financial Group's XERS Position: Q1 2026 in Review

Larson Financial Group opened a new position in Xeris Biopharma Holdings (XERS) in Q1 2026: 104 shares worth $603. The stake represents ﹤0.01% of the portfolio and ranks #3280 among its holdings. This is a return to the name: Larson Financial Group previously reported a position in XERS as recently as Q3 2025.

Larson Financial Group first reported a position in XERS in Q3 2025 and has held it in 2 quarters since. The position peaked at $3.26K in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Larson Financial Group held 104 shares of Xeris Biopharma Holdings worth $603 as of Q1 2026.
  • Xeris Biopharma Holdings was a new Larson Financial Group position in Q1 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #3280 holding.
  • Larson Financial Group first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 2 quarters since.
  • Larson Financial Group's Xeris Biopharma Holdings position peaked at $3.26K in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.